| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 8, Issue 5 541-551, Copyright © 1997 by American Association of Cancer Research
ARTICLES |
S Gopalakrishnan, JL Douglas and MP Quinlan
Department of Microbiology and Immunology, University of Tennessee, Memphis 38163, USA.
Immortalization of primary cells is an early and important event in multistep tumorigenesis and is itself a multistep process. Adenovirus E1A 12S encodes an oncoprotein that can rescue cells from senescence and overcome apoptosis, leading to their immortalization. Five regions of 12S, located in both exons, are required for immortalization. Two regions in the first exon are necessary to activate the cell cycle, increase the number of population doublings, and overcome the M1 stage of mortality. However, extension of life span requires overcoming crisis or M2, which can be accomplished by the expression of the second exon. Several cellular proteins associate with the peptide encoded by the first exon of 12S including pRB, p107, p130, and p300. The importance of pRB-E1A and p300-E1A complexes in transformation is well established; however, their roles in 12S-mediated immortalization remain undefined. Results obtained from the present study using a panel of second exon immortalization-defective mutants demonstrate that formation of pRB-E1A and p300-E1A complexes is insufficient for immortalization of primary cells. We further demonstrate that the expression levels of another tumor suppressor protein, p53, also do not correlate with the inability of the mutants to immortalize. Thus, mutations in the second exon of 12S do not affect the early steps in the immortalization pathway. The second exon mutants are defective in performing a late function in immortalization, involving the reactivation of the cell cycle, indicating that it is a crucial event in immortalization.
This article has been cited by other articles:
![]() |
L.-J. Zhao, T. Subramanian, and G. Chinnadurai Changes in C-terminal Binding Protein 2 (CtBP2) Corepressor Complex Induced by E1A and Modulation of E1A Transcriptional Activity by CtBP2 J. Biol. Chem., December 1, 2006; 281(48): 36613 - 36623. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Madison, P. Yaciuk, R. P. S. Kwok, and J. R. Lundblad Acetylation of the Adenovirus-transforming Protein E1A Determines Nuclear Localization by Disrupting Association with Importin-alpha J. Biol. Chem., October 4, 2002; 277(41): 38755 - 38763. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Fernandes and R. J. Rooney Suppression of E1A-Mediated Transformation by the p50E4F Transcription Factor Mol. Cell. Biol., July 1, 1999; 19(7): 4739 - 4749. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Fischer and M. P. Quinlan Expression of the pRb-Binding Regions of E1A Enables Efficient Transformation of Primary Epithelial Cells by v-src J. Virol., April 1, 1998; 72(4): 2815 - 2824. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |